U.S. Software Stock News

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

We feel now is a pretty good time to analyse LifeStance Health Group, Inc.'s ( NASDAQ:LFST ) business as it appears the...

On October 22, 2025, DataVault AI, Inc. and Wellgistics Health, Inc. announced a non-binding letter of intent to integrate manufacturer-to-patient blockchain-enabled smart contracts into Wellgistics' prescription drug infrastructure, aiming to fully digitize tracking from script to fulfillment across more than 6,500 pharmacies nationwide. A unique aspect of this partnership is its focus on leveraging AI agents and digital routing tools to optimize prescription drug services while enhancing...

If you're wondering what to do with Hexcel stock after its recent run, you're not alone. With the share price closing at $72.79 and up a whopping 17.8% over the last week alone, Hexcel has grabbed investors' attention in a serious way. Zooming out, the stock has gained 14.9% over the last 30 days and is up 124.6% over five years. A multiyear climb like this naturally gets investors asking if there is still value left on the table, or if all the growth is already priced in. A quick look at...

Thinking about what to do with TKO Group Holdings stock? If you own shares or are sizing up an entry, you’re probably weighing not only its impressive run but also wondering whether there is real value left or just excitement. TKO has certainly been hard to ignore. The stock has surged 63.6% over the past year, and it is up 30.9% year-to-date, showing strength most markets would envy. Even after a recent dip of 1.3% in the last week and a 6.1% slide over the last month, it is clear that the...

Sify Technologies (NasdaqCM:SIFY) remains in the red, with losses deepening at an average rate of 60.8% per year over the past five years. Although the company trades at a premium price-to-sales ratio of 1.9x compared to the US Telecom industry’s 1.2x average and its peers at 1.4x, forecasts call for a turnaround. Earnings are projected to surge 158.14% per year, with profitability expected within three years and revenue tipped to grow 30.1% annually, well ahead of the 10.1% US market pace...

If you’ve found yourself eyeing Graham Holdings after its most recent moves, you’re not alone. Whether you’re considering holding, trimming, or jumping in fresh, the stock’s behavior lately has gotten plenty of investors talking. Despite facing a pullback of 13.7% over the last 30 days, which might have rattled less seasoned hands, Graham Holdings is still up an impressive 18.1% year to date and 33.8% over the past year. Step back further, and you see gains of 67.4% across three years and...

Ventyx Biosciences recently announced positive topline results from its Phase 2 clinical trial of VTX3232, showing significant reductions in key inflammatory biomarkers such as hsCRP and IL-6 in patients with obesity and cardiovascular risk factors. An interesting insight from the study is that VTX3232 achieved a robust safety and tolerability profile, both as a standalone therapy and in combination with semaglutide, highlighting its potential as a new oral anti-inflammatory option in...

If you’ve been eyeing CECO Environmental and wondering whether it’s time to get in, stay patient, or take wins off the table, you’re not alone. This stock has been quietly (and not so quietly) rewarding attentive investors with some eye-popping returns. Just check out the numbers: up 6.7% over the past week, 5.9% in the last month, and an astonishing 66.1% so far this year. Zoom out further, and the gains are even more impressive: nearly 95% for the past year and a staggering 637% over the...

If you are weighing your next move with Old National Bancorp, you are certainly not alone. Investors are taking note as this regional bank’s stock has delivered a rollercoaster of returns lately. In just the past week, shares have climbed 6.0%, a sharp turnaround from last month’s dip of almost 5%. With a strong 15.4% return over the last year and an impressive 76.6% gain across five years, Old National has shown that its long-term story is anything but boring. What is driving these swings?...

Paul Mueller (MUEL) posted a noteworthy turnaround in its recent earnings, swinging to profitability over the past year after a stretch of losses. Earnings have accelerated at an average annual rate of 41.3% over the last five years, and the company’s net profit margin has expanded as profitability returned. The latest data points to attractive value with shares trading below estimated fair value, but investors should keep an eye on the high proportion of non-cash earnings when weighing the...

If you’re wondering whether to keep holding, buy more, or finally part ways with Genpact, you’re not alone. The stock has been on a bit of a roller coaster, inviting both cautious observers and value hunters to the table. Over the past year, Genpact’s price has ticked up a respectable 4.5%, despite a choppy ride that includes a 6.4% dip over the past month and an overall 8.1% slide year-to-date. While that kind of short-term volatility might spook some investors, it can also mean opportunity,...

If you’re thinking about whether Opera is a buy, sell, or just one to keep on your watchlist, you’re not alone. In the last week, the stock slipped by 3.2%, following a choppier month where it dropped 17.2%. That might make some investors uneasy, but if you zoom out, Opera’s story gets a lot more interesting. Despite the recent turbulence, the stock is still up a massive 356.5% over three years and 116.2% over the last five years. So, what’s driving these swings, and what could that mean for...

Affinity Bancshares (AFBI) reported a net profit margin of 23.7%, up from 18.3% a year ago, underscoring higher profitability relative to revenue. Earnings growth surged 34.5% year over year, materially above the company’s 5-year average of 3.4% per year and further highlighted by management as high quality. With margins improving and consistent profit gains, investors are likely to take note of both the stronger bottom line and the context of higher valuation multiples compared to industry...

Bullish momentum is building around Churchill Capital Corp X (CCCX) as options traders pile into call contracts. Volumes have doubled the norm and implied volatility is spiking. The extremely low Put/Call Ratio suggests that optimism is widespread. See our latest analysis for Churchill Capital Corp X. After a quiet start to the year, Churchill Capital Corp X’s share price has climbed significantly in recent weeks, notching a 51.8% gain over the past month and doubling since the beginning of...

Core Scientific (CORZ) extended its streak of unprofitability this quarter, with net losses having grown at an average rate of 23.1% per year over the past five years. Looking ahead, analysts forecast an 83.98% annual growth in earnings and expect the company to achieve profitability within three years, while revenue is projected to expand at 36.3% per year, well above the US market average. Despite these optimistic growth projections, Core Scientific’s net profit margin has yet to show...

Caledonia Mining Corporation Plc recently reported gold production of 19,106 ounces for the third quarter of 2025 and reiterated its increased 2025 annual production guidance of 75,500 to 79,500 ounces. This consistent operational performance and reaffirmed outlook highlight management’s confidence in delivering stable gold output despite previous periods of investor scrutiny. We'll explore how the company's reaffirmed 2025 gold production guidance could shape Caledonia Mining's investment...

Thinking about what’s next for Motorola Solutions stock? You’re not alone. With shares recently closing at $438.98, investors are trying to determine whether it’s time to double down or take some gains off the table. Over the past year, the stock has drifted lower, down 4.1%, and it has shed 4.4% year-to-date. Even the shorter-term moves have been a bit uninspiring, with a 3.8% slip in the last month and a 1.4% dip over the past week. However, not everything is as quiet as it seems. Zoom out...

If you are puzzling over what to make of Solventum's stock right now, you are in good company. Over the past month, shares have barely budged, up just 0.1%, even as the overall market has moved with more conviction. That kind of flat performance can frustrate momentum seekers, but for the valuation-conscious, it might hint at opportunity or a story that is still developing. Digging a bit into the recent price action, Solventum is up a healthy 8.4% so far this year, quickly bouncing back from...

World Kinect (NYSE:WKC) remains unprofitable, with losses deepening at an average rate of 45.7% per year over the last five years and no improvement in its net profit margin this year. Revenue is forecast to edge down slightly by 0.01% per year in the near term, but the major storyline is an expected earnings turnaround. Analysts see profits growing by 125.91% per year, with the company potentially returning to profitability within three years, an outlook that stands out in the sector. See...

Trying to figure out what to do with CSX stock right now? You're not alone. After another month of strong gains, with shares up 6.2% over the last 30 days and a year-to-date return at a solid 12.3%, investors are wondering if the growth train has enough steam left or if it’s time to lock in some profits. Despite a slight dip of 1.3% this past week, CSX has delivered a healthy 46.7% total return over the past five years. This performance puts it ahead of many peers in the transportation...

First Capital (FCAP) posted net profit margins of 31.2%, an improvement over last year’s 28.7%. Earnings growth surged by 25.1%, which is well above the company’s five-year average of 4.9% per year. Shares are trading at $42.92, below the estimated fair value of $72.33. This suggests potential for upside as investors take note of the company’s high-quality and accelerating earnings profile. See our full analysis for First Capital. Next, we’ll see how these latest numbers compare to the...